Since May, rare and unusual monkeypox outbreaks have occurred in many countries around the world. WHO reported on May 24 that 131 confirmed and 106 suspected cases of monkeypox have been reported in 19 countries.
In order to effectively deal with the spread of monkeypox epidemic and accurately identify monkeypox viruses with different pathogenicity, BACME Biotech successfully developed the "Monkeypox Virus PCR Test Kit (Realtime PCR)".
This kit adopts BACME’s patent of "high-sensitivity nucleic acid detection technology", combined with fluorescent probes, to achieve a single-tube five-channel detection for monkeypox virus, which can simultaneously distinguish orthopox virus (general), smallpox virus, monkeypox virus and internal control. It has the characteristics of high sensitivity and high performance, which can contribute to the rapid diagnosis and prevention and control of monkeypox.
BACME Biotech's product "Monkeypox Virus PCR Test Kit (Realtime PCR)" has obtained the CE certificate
Product Appearance
